Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HFNC Versus Conventional Nasal Cannula During EBUS Procedure: a Randomised Controlled Trial

NCT06637280 is registered in ClinicalTrials.gov with The University Clinic of Pulmonary and Allergic Diseases Golnik as lead sponsor.

NCT NCT06637280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06637280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HFNC Versus Conventional Nasal Cannula During EBUS Procedure: a Randomised Controlled Trial
Lead sponsor
The University Clinic of Pulmonary and Allergic Diseases Golnik
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2024
Completion date
November 1, 2024
Enrollment
150 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxemia during ebus bronchoscopy